BC
MIST icon

BIT Capital’s Milestone Pharmaceuticals MIST Stock Holding History

BIT Capital’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,000
Closed -$33.4K – 125
2023
Q4 		$33.4K Sell
20,000
-187,276
-90% -$508K ﹤0.01% 95
2023
Q3 		$643K Hold
207,276
– – 0.08% 66
2023
Q2 		$591K Buy
207,276
+9,000
+5% +$33.9K 0.05% 91
2023
Q1 		$781K Buy
198,276
+136,776
+222% +$500K 0.11% 77
2022
Q4 		$244K Buy
+61,500
New +$324K 0.05% 110

Other funds holding MIST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT Capital's MIST Position: Q1 2024 in Review

BIT Capital sold out of Milestone Pharmaceuticals (MIST) in Q1 2024, closing a stake of 20,000 shares — an estimated $33.4K sold.

BIT Capital first reported a position in MIST in Q4 2022 and held it in 5 quarters. The position peaked at $781K in Q1 2023. 44 funds tracked by Wall St. Rank hold MIST as of Q1 2024.

  • BIT Capital reported no remaining Milestone Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • BIT Capital sold 20,000 Milestone Pharmaceuticals shares in Q1 2024, an estimated $33.4K.
  • BIT Capital first reported a position in Milestone Pharmaceuticals in Q4 2022 and held it in 5 quarters.
  • BIT Capital's Milestone Pharmaceuticals position peaked at $781K in Q1 2023.
  • 44 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2024.

Based on BIT Capital's 13F filing for Q1 2024, filed 12 Feb 2025.